Factors impacting time to acceptance and publication for peer-reviewed publications-Reference-Cited by-同舟云学术

Factors impacting time to acceptance and publication for peer-reviewed publications

Published:2016-12-31 Issue:7 Volume:33 Page:1183-1189
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Toroser Dikran¹,Carlson Janice¹,Robinson Micah¹,Gegner Julie¹,Girard Victoria¹,Smette Lori¹,Nilsen Jon¹,O’Kelly James²

Affiliation:

1. Amgen Inc., Thousand Oaks, CA, USA;

2. Amgen Ltd, Uxbridge, UK

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2016.1271778

Reference9 articles.

1. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

2. Rationale for WHO's New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results

3. World Health Organization. WHO Statement on Public Disclosure of Clinical Trial Results. Available at: http://www.who.int/ictrp/results/reporting [Last accessed 11 May 2016]

4. Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study

5. Publication efficiency among the higher impact factor nursing journals in 2009: A retrospective analysis

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On the peer review reports: does size matter?;Scientometrics;2024-03-11

2. Orthopaedic Surgeons Should Consider Online and E-publication Resources for the Most Current Evidence-Based Medicine Following the COVID-19 Pandemic;Arthroscopy, Sports Medicine, and Rehabilitation;2023-08

3. Analysis of the interval between submission and publication in genetics journals;PLOS ONE;2023-05-17

4. All-pervading insider bias alters review time in Turkish university journals;Scientometrics;2023-05-13

5. Time from submission to publication in urology journals: A look at publication times before and during Covid-19;Heliyon;2023-03